🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.

Service Response and Material Removal

Based on the social media company, the service has taken down problematic content and prohibited associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.

After minutes of entering one community, a seller posted WhatsApp details, where most purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Details and Costs

Within these communities, posts show black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When questioned how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose users to possibly serious health risks”.